PhagoStim. Dysphagia Treatment with Neuromuscular Electrostimulation – A randomized Trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00017480

Enrollment

Registered

2019-06-18

Start date

2012-01-23

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

R13

Interventions

Group 1: neuromuscular electrical Stimulation + traditional dysphagia therapy Group 2: sham stimulation + traditional dysphagia therapy

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: male and female patients with dysphagia after stroke, post-acute phase

Exclusion criteria

Exclusion criteria: Non-consent, pregnancy, diseases of the upper esophageal sphincter, tumors, pacemakers, cranial stimulators as well as metal implants in the head and neck represented as exclusion criteria.

Design outcomes

Primary

Measure	Time frame
Baseline and post-trial measurements were done by Fiberoptic endoscopic evaluation of swallowing (FEES) in combination with Dysphagia Outcome and Severity Scale (DOSS) (primary outcome measure).	—

Secondary

Measure	Time frame
Secretion Scale by Murray, Glottic closure by Murray, Penetration and Aspiration Scale (PAS) and throat clearance abilities.	—

Countries

Germany

Contacts

Public ContactMartin Ptok

Medizinische Hochschule Hannover

miller.simone@mh-hannover.de+495115325778

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026